Woodline Partners’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9M | Buy |
3,505,893
+2,027,986
| +137% | +$8.64M | 0.08% | 349 |
|
|
2025
Q1 | $5.56M | Buy |
1,477,907
+120,428
| +9% | +$453K | 0.04% | 481 |
|
|
2024
Q4 | $7.91M | Buy |
1,357,479
+3,293
| +0.2% | +$19.2K | 0.05% | 396 |
|
|
2024
Q3 | $16.2M | Buy |
1,354,186
+501,632
| +59% | +$5.99M | 0.14% | 215 |
|
|
2024
Q2 | $9.22M | Buy |
852,554
+102,275
| +14% | +$1.11M | 0.09% | 256 |
|
|
2024
Q1 | $8.49M | Hold |
750,279
| – | – | 0.08% | 292 |
|
|
2023
Q4 | $10.5M | Buy |
750,279
+32,947
| +5% | +$462K | 0.11% | 224 |
|
|
2023
Q3 | $8.86M | Buy |
717,332
+129,280
| +22% | +$1.6M | 0.1% | 238 |
|
|
2023
Q2 | $5.31M | Buy |
+588,052
| New | +$5.31M | 0.06% | 277 |
|